Tribunal Orders Composite Scheme of Arrangement for Apollo Hospitals Enterprise Limited and Associates
Apollo Hospitals Enterprise Limited received a certified true copy of the order dated March 26, 2026, from the National Company Law Tribunal, Division Bench - II, Chennai. The order pertains to the proposed composite scheme of arrangement involving Apollo Hospitals Enterprise Limited, Apollo Healthco Limited, Keimed Private Limited, and Apollo Healthtech Limited, along with their respective shareholders and creditors.The company received the Order on April 9, 2026. The Tribunal passed the order in relation to the application CA (CAA)/8 / (CHE) I 2026, which was jointly filed by the four entities under Sections 230 to 232 of the Companies Act, 2013.
Company Details and Capital Structure
The participating entities involved in the arrangement are detailed as follows:| Entity Name | CIN | Role in Scheme |
|---|---|---|
| Apollo Hospitals Enterprise Limited | L85110TN1979PLC008035 | Demerged Company |
| Apollo Healthco Limited | U85110TN2020PLC135839 | Transferor Company 1 |
| Keimed Private Limited | U72200TN2000PTC179280 | Transferor Company 2 |
| Apollo Healthtech Limited | U63122TN2025PLC180534 | Resultant Company |
Share Capital Snapshot:
| Company | Authorized Share Capital (Rs.) | Issued, Subscribed and Paid Up Share Capital (Rs.) |
|---|---|---|
| Apollo Hospitals Enterprise Limited | 1,10,00,00,000 | 71,89,23,285 |
| Apollo Healthco Limited | 29,25,00,00,000 | 28,86,19,94,770 |
| Keimed Private Limited | 62,01,00,000 | 6,87,29,370 |
| Apollo Healthtech Limited | 5,00,00,000 | 9,00,000 |
Key Directives from the Tribunal Order
The Tribunal issued several directions regarding the scheme's approval processes for each entity:* Apollo Hospitals Enterprise Limited (Demerged Company):
* The meeting of Equity Shareholders was directed to be convened on May 16, 2026, at 09:00 A.M.
* The meeting of Secured Creditors was directed to be convened on May 16, 2026, at 12:00 P.M.
* The meeting of Unsecured Creditors was directed to be convened on May 16, 2026, at 03:00 P.M.
* Apollo Healthco Limited (Transferor Company 1):
* The meeting of Unsecured Creditors was directed to be convened on May 17, 2026, at 10:00 A.M.
* Keimed Private Limited (Transferor Company 2):
* The meeting of Unsecured Creditors was directed to be convened on May 17, 2026, at 01:00 P.M.
* Apollo Healthtech Limited (Resultant Company):
* The necessity to convene meetings for all classes of stakeholders was dispensed with, as there were NIL Secured Creditors and NIL Unsecured Creditors, and the company had 100% shareholder consent.
The Tribunal also established the quorum requirements for the meetings. For the Demerged Company, the quorum for Shareholders was set at 35,640, and for Unsecured Creditors at 1296.
Rationale for the Scheme
The stated rationale for the composite scheme includes enabling the carving-out of the Identified Business Undertaking from Apollo Hospitals Enterprise Limited. This demerger aims to allow both the Demerged Company and the Resultant Company to focus on respective business areas, improve management, and explore opportunities more efficiently. The scheme is also expected to consolidate the pharmacy distribution business of Apollo Healthco Limited and Keimed Private Limited into an independent entity focusing on digital health and pharmacy distribution. Overall, the arrangement aims to enhance resource utilization, improve supply chain transparency, and promote business growth by enabling integration and economies of scale.APOLLOHOSP Stock Price Movement
Shares of Apollo Hospitals Enterprise Limited are edging higher to ₹7526.5 as of 3:28 PM, gaining ₹45.00, or 0.60% in live trading. This upward momentum arrives amidst significant volume, with 427,625 shares traded during the session.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.